MRVL vs TECH · P/E 100, rev $8.19B vs P/E 65, rev $1.22B
Marvell Technology Group Ltd (MRVL) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MRVL revenue for 2026-01-31 was $8.19B. Net income was $2.67B. Revenue was up 42.1% from 2025-02-01 to 2026-01-31. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MRVL currently screens at market cap $253.51B and trailing P/E 99.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MRVL and TECH stock pages for the full models.
Not investment advice.